继发于视网膜静脉阻塞的全层黄斑裂孔的研究进展  

Research of full thickness macular hole secondary to retinal vein occlusion

作　　者：吴夕瑾 刘武[1] Wu Xijin;Liu Wu(Beijing Tongren Eye Center,Beijing Tongren Hospital,Capital Medical University,Bejing Key Laboratory of Ophthalmology and Visual Sciences,Beijing 100730,China)

机构地区：[1]首都医科大学附属北京同仁医院、北京同仁眼科中心、眼科学与视光科学北京市重点实验室,北京100730

出　　处：《中华眼底病杂志》2023年第9期783-786,共4页Chinese Journal of Ocular Fundus Diseases

基　　金：国家重点研发计划(2017YFA0104103)。

摘　　要：继发于视网膜静脉阻塞(RVO)的全层黄斑裂孔(FTMH)临床较为少见。此类裂孔的临床特征各不相同,可能与黄斑囊样水肿、视网膜前膜等并发症及玻璃体腔注射药物等治疗手段相关。FTMH主要手术方式为玻璃体切割联合内界膜剥除手术,手术后大部分裂孔可达解剖愈合,但其手术后裂孔闭合率、疾病及视功能预后尚不明确。密切的随诊与定期复查,必要时及时行玻璃体切割手术干预有助于改善患者的预后。今后仍需更大样本量的随机对照临床试验进一步探索其发生机制、临床特征以及治疗方法,以期更好地改善RVO后FTMH患者的临床预后。Full thickness macular hole(FTMH)is a rare complication of retinal vein occlusion(RVO).These have different characteristics,and may associate with complications of RVO,such as cystoid macular edema and epiretinal membrane,and treatments like intravitreal injection.Although anatomical closure is often obtained with vitrectomy and inner limiting membrane peeling,visual improvement is often variable.Regularly follow-up,medical examination,and vitrectomy can improve the outcomes of patients.In the future,randomized controlled clinical trials with larger sample size are still needed to further explore the pathogenesis,clinical characteristics and treatment methods of FTMH after RVO,so as to improve the clinical prognosis of these patients.

关 键 词：黄斑裂孔 视网膜静脉阻塞 黄斑水肿 综述 

分 类 号：R774[医药卫生—眼科]